Læknablaðið - 15.10.1986, Síða 7

LÆKNABLAÐIÐ
245
Pike MC, Siiteri PK, Welch CW, eds. Banbury
Report 8. Hormones And Breast Cancer, Cold
Spring Harbour Laboratory 1981: 229-39.
6. Boggs Dr, Winkelstein A. White cell manual, 4th
ed. Philadelphia: F. A. Davis Company, 1983.
7. Rai KR, Sawitsky A, Cronkite EP, Chanana AD,
Levy RN, Pasternack BS. Clinical staging of
chronic lymphocytic leukemia. Blood 1975, 46:
219-34.
8. Simondsson B, Nilsson K, Terenius L, Glimelius B.
Biochemical characteristics of chronic lymphocytic
leukemia. Scand J Haematol 1978; 21: 379-89.
9. McGuire WL, DeLaCarza M. Improved sensitivity
in the measurement of estrogen receptor in human
breast cancer. J Clin Endocrinol Metab 1973; 37:
986-9.
10. Narasimhan P, Amaral L. Lymphopaenic response
of patients presenting with chronic lymphocytic
leukemia associated with carcinoma of the prostate
with diethylstilbestrol. Am J Haematol 1980; 8:
369-75.
11. Narashiman P. Estrogen receptor activity in
Hodgkin’s disease. Ann Intern Med 1981; 95: 653
(letter).
12. Rosen St, Maciorowski Z, Wittlin F, et al. Estrogen
receptor analysis in chronic lymphocytic leukemia.
Blood 1983; 62: 996-9.
13. Stark JJ, Lloyd JW, Schellhammer PF. Estrogen
receptor activity in a case of Hodgkin’s disease.
Ann Intern Med 1981; 95: 186-7 (letter).
14. Morgan D. Estrogen receptors and lymphocytic
lymphoma. Ann Intern Med 1981; 95: 783-79.
15. Ablin RJ, Burns GR, Guinan PD, Sheik HA, Bush
IM. Hormonal therapy and alteration of
lymphocyte proliferation. J Lab Clin Med 1976; 87:
227-31.
16. Grossman CJ, Sholiton LJ, Rosell GA. Estradiol
regulation of thymic lymphocyte function in the rat:
Mediation by serum thymic factors. J Steroid
Biochem 1982; 16: 683-90.
17. Barr IG, Khalid BAK, Pearce P, et al.-
Dihydrotestosterone and estradiol deplete
corticosensitive thymocytes lacking in receptors for
these hormones. J Immunol 1982; 128: 2825-8.